This immune dysregulation results in a wide range of symptoms and manifestations, including but not limited to skin rashes, joint pain, kidney dysfunction, cardiovascular complications, and neurological abnormalities
[5] [6] La evidencia de ensayos como LEADER (liraglutida) y REWIND (dulaglutida) sugiere que los beneficios cardiovasculares y renales de estos medicamentos persisten mientras se mantiene el tratamiento, aunque estos beneficios varan segn el agente especfico
It is also approved for weight loss in people with obesity or overweight who have at least one other health condition
Nat Med 17, 10761085, doi: 10.1038/nm.2439 (2011)
Ozempic, Wegovy, Mounjaro, and Zepbound are a glucagon-like peptide-1 (GLP-1) agonist
Many people appreciate this slower pace because it aligns closely with natural GH rhythms and is often well suited for long-term use